Protein inhibitor of activated STAT genes are differentially expressed in breast tumor tissues.
Goal: Protein inhibitor of activated STAT (PIAS) household consists of transcriptional regulator proteins with SUMO E3 ligase exercise. They regulate expression of a number of genes concerned in cell proliferation, differentiation and survival.
Methodology: We evaluated expression of PIAS1-4 genes in 54 breast most cancers tissues and their paired adjoining noncancerous tissues.
Outcomes:PIAS2 and PIAS3 genes had been considerably downregulated in tumoral tissues in contrast with adjoining noncancerous tissues. PIAS1-3 expressions had been considerably decrease in estrogen receptor (ER+) samples in contrast with ER- samples whereas PIAS4 had the other pattern. PIAS3 expression was considerably greater in grade 1 samples in contrast with grade 2 samples.
Conclusion: These findings spotlight the position of PIAS genes within the pathogenesis of breast most cancers and their affiliation with determinants of response to antihormone therapies.
Dendritic Cell Focusing on of Bovine Viral Diarrhea Virus E2 ProteinExpressed by Lactobacillus casei Successfully Induces Antigen-Particular Immune Responses through Oral Vaccination.
Bovine viral diarrhea brought on by bovine viral diarrhea virus (BVDV) is a crucial illness in cattle, leading to important financial losses to the cattle trade worldwide. As a way to develop an efficient vaccine in opposition to BVDV an infection, we constructed a dendritic cell (DC)-targeting oral probiotic vaccine (pPG-E2-DCpep/LC W56) utilizing Lactobacillus casei as antigen supply provider to specific BVDV glycoprotein E2 fused with DC-targeting peptide, and the immunogenicity of orally administered probiotic vaccine was evaluated in mice mannequin.
Our outcomes confirmed that after immunization with the probiotic vaccine, considerably ranges of antigen-specific sera IgG and mucosal sIgA antibodies (p < 0.05) with BVDV-neutralizing exercise had been induced in vivo. Problem experiment confirmed that pPG-E2-DCpep/LC W56 can present efficient immune safety in opposition to BVDV, and BVDV may very well be successfully cleared from the gut of immunized mice post-challenge. Furthermore, the pPG-E2-DCpep/LC W56 may effectively activate DCs within the intestinal Peyer’s patches, and considerably ranges of lymphoproliferative responses,
Th1-associated IFN-γ, and Th2-associated IL-Four had been noticed in mice immunized with pPG-E2-DCpep/LC W56 (p < 0.01). Our outcomes clearly exhibit that the probiotic vaccine may effectively induce anti-BVDV mucosal, humoral, and mobile immune responses through oral immunization, indicating a promising technique for the event of oral vaccine in opposition to BVDV.

DNAJB14 Antibody |
|||
DF12198 | Affbiotech | 200ul | EUR 420 |
DNAJB14 Antibody |
|||
1-CSB-PA007007GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against DNAJB14. Recognizes DNAJB14 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
DNAJB14 Polyclonal Antibody |
|||
30628-100ul | SAB | 100ul | EUR 302.4 |
DNAJB14 Polyclonal Antibody |
|||
30628-50ul | SAB | 50ul | EUR 224.4 |
DNAJB14 Polyclonal Antibody |
|||
A72739-050 | EpiGentek | 50 ul | EUR 302.5 |
DNAJB14 Polyclonal Antibody |
|||
A72739-100 | EpiGentek | 100 ul | EUR 423.5 |
DNAJB14 Polyclonal Antibody |
|||
A66234-020 | EpiGentek | 20 ul | EUR 117.7 |
DNAJB14 Polyclonal Antibody |
|||
A66234-050 | EpiGentek | 50 ul | EUR 302.5 |
DNAJB14 Polyclonal Antibody |
|||
A66234-100 | EpiGentek | 100 ul | EUR 423.5 |
DNAJB14 Polyclonal Antibody |
|||
A66234 | EpiGentek |
|
|
DNAJB14 Polyclonal Antibody |
|||
A72739 | EpiGentek |
|
|
DNAJB14 siRNA |
|||
20-abx914343 | Abbexa |
|
|
DNAJB14 siRNA |
|||
20-abx914344 | Abbexa |
|
|
DNAJB14 Antibody, HRP conjugated |
|||
1-CSB-PA819454LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against DNAJB14. Recognizes DNAJB14 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
DNAJB14 Antibody, FITC conjugated |
|||
1-CSB-PA819454LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against DNAJB14. Recognizes DNAJB14 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
DNAJB14 Antibody, Biotin conjugated |
|||
1-CSB-PA819454LD01HU | Cusabio |
|
|
Description: A polyclonal antibody against DNAJB14. Recognizes DNAJB14 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
DNAJB14 Polyclonal Conjugated Antibody |
|||
C30628 | SAB | 100ul | EUR 476.4 |
DNAJB14 Rabbit pAb |
|||
A4990-100ul | Abclonal | 100 ul | EUR 369.6 |
DNAJB14 Rabbit pAb |
|||
A4990-200ul | Abclonal | 200 ul | EUR 550.8 |
DNAJB14 Rabbit pAb |
|||
A4990-20ul | Abclonal | 20 ul | EUR 219.6 |
DNAJB14 Rabbit pAb |
|||
A4990-50ul | Abclonal | 50 ul | EUR 267.6 |
DNAJB14 Blocking Peptide |
|||
DF12198-BP | Affbiotech | 1mg | EUR 234 |
DNAJB14 cloning plasmid |
|||
CSB-CL819454HU-10ug | Cusabio | 10ug | EUR 279.6 |
Description: A cloning plasmid for the DNAJB14 gene. |
DNAJB14 Polyclonal Antibody, HRP Conjugated |
|||
A66235-050 | EpiGentek | 50 ul | EUR 302.5 |
DNAJB14 Polyclonal Antibody, HRP Conjugated |
|||
A66235-100 | EpiGentek | 100 ul | EUR 423.5 |
DNAJB14 Polyclonal Antibody, FITC Conjugated |
|||
A66236-050 | EpiGentek | 50 ul | EUR 302.5 |
DNAJB14 Polyclonal Antibody, FITC Conjugated |
|||
A66236-100 | EpiGentek | 100 ul | EUR 423.5 |
DNAJB14 Polyclonal Antibody, Biotin Conjugated |
|||
A66237-050 | EpiGentek | 50 ul | EUR 302.5 |
DNAJB14 Polyclonal Antibody, Biotin Conjugated |
|||
A66237-100 | EpiGentek | 100 ul | EUR 423.5 |
DNAJB14 Polyclonal Antibody, HRP Conjugated |
|||
A66235 | EpiGentek |
|
|
DNAJB14 Polyclonal Antibody, FITC Conjugated |
|||
A66236 | EpiGentek |
|
|
DNAJB14 Polyclonal Antibody, Biotin Conjugated |
|||
A66237 | EpiGentek |
|
|
Polyclonal Goat anti-GST α-form |
|||
GST-ANTI-1 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST μ-form |
|||
GST-ANTI-2 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST p-form |
|||
GST-ANTI-3 | Detroit R&D | 50 uL | EUR 336 |
Mouse DNAJB14 shRNA Plasmid |
|||
20-abx977260 | Abbexa |
|
|
Human DNAJB14 shRNA Plasmid |
|||
20-abx962706 | Abbexa |
|
|
DNAJB14 ELISA KIT|Human |
|||
EF009156 | Lifescience Market | 96 Tests | EUR 826.8 |
DNAJB14 Recombinant Protein (Human) |
|||
RP009529 | ABM | 100 ug | Ask for price |
DNAJB14 Recombinant Protein (Rat) |
|||
RP198299 | ABM | 100 ug | Ask for price |
DNAJB14 Recombinant Protein (Mouse) |
|||
RP129476 | ABM | 100 ug | Ask for price |
Dnajb14 ORF Vector (Rat) (pORF) |
|||
ORF066101 | ABM | 1.0 ug DNA | EUR 607.2 |
DNAJB14 ORF Vector (Human) (pORF) |
|||
ORF003177 | ABM | 1.0 ug DNA | EUR 114 |
Dnajb14 ORF Vector (Mouse) (pORF) |
|||
ORF043160 | ABM | 1.0 ug DNA | EUR 607.2 |
DNAJB14 sgRNA CRISPR Lentivector set (Human) |
|||
K0614501 | ABM | 3 x 1.0 ug | EUR 406.8 |
Dnajb14 sgRNA CRISPR Lentivector set (Mouse) |
|||
K4586901 | ABM | 3 x 1.0 ug | EUR 406.8 |
Dnajb14 sgRNA CRISPR Lentivector set (Rat) |
|||
K6216401 | ABM | 3 x 1.0 ug | EUR 406.8 |
DnaJ (Hsp40) Homolog, Subfamily B, Member 14 (DNAJB14) Antibody |
|||
20-abx003806 | Abbexa |
|
|
DnaJ (Hsp40) Homolog, Subfamily B, Member 14 (DNAJB14) Antibody |
|||
20-abx112129 | Abbexa |
|
|
DnaJ (Hsp40) Homolog, Subfamily B, Member 14 (DNAJB14) Antibody |
|||
20-abx302018 | Abbexa |
|
|
DnaJ (Hsp40) Homolog, Subfamily B, Member 14 (DNAJB14) Antibody |
|||
abx232446-100ug | Abbexa | 100 ug | EUR 577.2 |
DNAJB14 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K0614502 | ABM | 1.0 ug DNA | EUR 184.8 |
DNAJB14 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K0614503 | ABM | 1.0 ug DNA | EUR 184.8 |
DNAJB14 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K0614504 | ABM | 1.0 ug DNA | EUR 184.8 |
Dnajb14 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K4586902 | ABM | 1.0 ug DNA | EUR 184.8 |
Dnajb14 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K4586903 | ABM | 1.0 ug DNA | EUR 184.8 |
Dnajb14 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K4586904 | ABM | 1.0 ug DNA | EUR 184.8 |
Dnajb14 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K6216402 | ABM | 1.0 ug DNA | EUR 184.8 |
Dnajb14 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K6216403 | ABM | 1.0 ug DNA | EUR 184.8 |
Dnajb14 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K6216404 | ABM | 1.0 ug DNA | EUR 184.8 |
DNAJB14 Protein Vector (Human) (pPB-C-His) |
|||
PV012705 | ABM | 500 ng | EUR 394.8 |
DNAJB14 Protein Vector (Human) (pPB-N-His) |
|||
PV012706 | ABM | 500 ng | EUR 394.8 |
DNAJB14 Protein Vector (Human) (pPM-C-HA) |
|||
PV012707 | ABM | 500 ng | EUR 394.8 |
DNAJB14 Protein Vector (Human) (pPM-C-His) |
|||
PV012708 | ABM | 500 ng | EUR 394.8 |
DNAJB14 Protein Vector (Mouse) (pPB-C-His) |
|||
PV172638 | ABM | 500 ng | EUR 723.6 |
DNAJB14 Protein Vector (Mouse) (pPB-N-His) |
|||
PV172639 | ABM | 500 ng | EUR 723.6 |
DNAJB14 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV172640 | ABM | 500 ng | EUR 723.6 |
DNAJB14 Protein Vector (Mouse) (pPM-C-His) |
|||
PV172641 | ABM | 500 ng | EUR 723.6 |
DNAJB14 3'UTR Luciferase Stable Cell Line |
|||
TU006138 | ABM | 1.0 ml | EUR 2799.6 |
Dnajb14 3'UTR GFP Stable Cell Line |
|||
TU253509 | ABM | 1.0 ml | Ask for price |
Dnajb14 3'UTR Luciferase Stable Cell Line |
|||
TU105250 | ABM | 1.0 ml | Ask for price |
DNAJB14 3'UTR GFP Stable Cell Line |
|||
TU056138 | ABM | 1.0 ml | EUR 2799.6 |
Dnajb14 3'UTR Luciferase Stable Cell Line |
|||
TU203509 | ABM | 1.0 ml | Ask for price |
Dnajb14 3'UTR GFP Stable Cell Line |
|||
TU155250 | ABM | 1.0 ml | Ask for price |
DNAJB14 Protein Vector (Rat) (pPB-C-His) |
|||
PV264402 | ABM | 500 ng | EUR 723.6 |
DNAJB14 Protein Vector (Rat) (pPB-N-His) |
|||
PV264403 | ABM | 500 ng | EUR 723.6 |
DNAJB14 Protein Vector (Rat) (pPM-C-HA) |
|||
PV264404 | ABM | 500 ng | EUR 723.6 |
DNAJB14 Protein Vector (Rat) (pPM-C-His) |
|||
PV264405 | ABM | 500 ng | EUR 723.6 |
DnaJ (Hsp40) Homolog, Subfamily B, Member 14 (DNAJB14) Antibody (HRP) |
|||
20-abx308795 | Abbexa |
|
|
DnaJ (Hsp40) Homolog, Subfamily B, Member 14 (DNAJB14) Antibody (FITC) |
|||
20-abx308796 | Abbexa |
|
|
DnaJ (Hsp40) Homolog, Subfamily B, Member 14 (DNAJB14) Antibody (Biotin) |
|||
20-abx308797 | Abbexa |
|
|
Human DnaJ Homolog Subfamily B Member 14 (DNAJB14) ELISA Kit |
|||
abx386930-96tests | Abbexa | 96 tests | EUR 1093.2 |
Human DnaJ homolog subfamily B member 14, DNAJB14 ELISA KIT |
|||
ELI-26399h | Lifescience Market | 96 Tests | EUR 988.8 |
Bovine DnaJ homolog subfamily B member 14, DNAJB14 ELISA KIT |
|||
ELI-31942b | Lifescience Market | 96 Tests | EUR 1113.6 |
Mouse DnaJ homolog subfamily B member 14, Dnajb14 ELISA KIT |
|||
ELI-08275m | Lifescience Market | 96 Tests | EUR 1038 |
DNAJB14 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K0614505 | ABM | 3 x 1.0 ug | EUR 451.2 |
Dnajb14 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K4586905 | ABM | 3 x 1.0 ug | EUR 451.2 |
Dnajb14 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
K6216405 | ABM | 3 x 1.0 ug | EUR 451.2 |
DNAJB14 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
K0614506 | ABM | 1.0 ug DNA | EUR 200.4 |
DNAJB14 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
K0614507 | ABM | 1.0 ug DNA | EUR 200.4 |
DNAJB14 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
K0614508 | ABM | 1.0 ug DNA | EUR 200.4 |
Dnajb14 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K4586906 | ABM | 1.0 ug DNA | EUR 200.4 |
Dnajb14 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K4586907 | ABM | 1.0 ug DNA | EUR 200.4 |
Dnajb14 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K4586908 | ABM | 1.0 ug DNA | EUR 200.4 |
Dnajb14 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
K6216406 | ABM | 1.0 ug DNA | EUR 200.4 |
Dnajb14 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
K6216407 | ABM | 1.0 ug DNA | EUR 200.4 |
Dnajb14 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
K6216408 | ABM | 1.0 ug DNA | EUR 200.4 |
Anti-Anti-SEPT6 antibody antibody |
|||
STJ11100949 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
Anti-Anti-SEPT9 Antibody antibody |
|||
STJ111369 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ111530 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT4 Antibody antibody |
|||
STJ112276 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
Anti-Anti-MARCH9 Antibody antibody |
|||
STJ112609 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ113941 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ114081 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ114819 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-MARCH8 Antibody antibody |
|||
STJ114828 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ116214 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ117206 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT12 Antibody antibody |
|||
STJ117759 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118549 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118550 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH7 Antibody antibody |
|||
STJ118752 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT3 Antibody antibody |
|||
STJ118990 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ28365 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ28963 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ25475 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ25477 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ25479 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT1 antibody antibody |
|||
STJ119580 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
Anti-Anti-DDB1 Antibody |
|||
A00333 | BosterBio | 100uL | EUR 546 |
Description: Rabbit Polyclonal DDB1 Antibody. Validated in IP and tested in Human, Mouse. |
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
AEA465Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 6777.36 |
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
AEA465Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 663.31 |
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
AEA465Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 896.16 |
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
AEA465Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 3672.72 |
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
4-AEA465Hu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species. |
ELISA kit for Human Anti-AsAb (Anti-Anti-Sperm Antibody Antibody) |
|||
ELK8071 | ELK Biotech | 1 plate of 96 wells | EUR 518.4 |
Description: A competitive Inhibition ELISA kit for detection of Anti-Anti-Sperm Antibody Antibody from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
Anti-ZNF660 antibody |
|||
44742-100ul | SAB | 100ul | EUR 302.4 |
Anti-ZNF660 antibody |
|||
44742-50ul | SAB | 50ul | EUR 224.4 |
Anti-CCV Antibody |
|||
10-2789 | Fitzgerald | 1 mg | EUR 217.2 |
Description: Anti-Canine Corona Virus Antibody |
Anti-CCV Antibody |
|||
10-2790 | Fitzgerald | 1 mg | EUR 217.2 |
Description: Anti-Canine Corona Virus Antibody |
Anti-CDV antibody |
|||
10-2791 | Fitzgerald | 1 mg | EUR 198 |
Description: Anti-Canine Distemper Virus antibody |
Anti-CDV antibody |
|||
10-2792 | Fitzgerald | 1 mg | EUR 198 |
Description: Anti-Canine Distemper Virus antibody |
Anti-CDV antibody |
|||
10-2793 | Fitzgerald | 1 mg | EUR 198 |
Description: Anti-Canine Distemper Virus antibody |
Anti-CDV antibody |
|||
10-2794 | Fitzgerald | 1 mg | EUR 198 |
Description: Anti-Canine Distemper Virus antibody |
Differentially expressed mRNAs, proteins and miRNAs related to vitality metabolism in skeletal muscle of beef cattle recognized for high and low residual feed consumption.
Feed effectivity is likely one of the most essential parameters that have an effect on beef manufacturing prices. The vitality metabolism of skeletal muscle drastically contributes to variations in feed effectivity.
- Nonetheless, info relating to variations in proteins concerned within the vitality metabolism of the skeletal muscle in beef cattle divergently recognized for feed effectivity is scarce.
- On this research, we aimed to analyze vitality metabolism of skeletal muscle of Nellore beef cattle, recognized for high and low residual feed consumption utilizing a proteomics strategy.
- We additional assessed the expression of candidate microRNAs as a one of many doable mechanisms controlling the biosynthesis of the proteins concerned in vitality metabolism that had been differentially ample between excessive and low residual feed consumption animals.
- A better abundance of 14-3-Three protein epsilon (P = 0.01) was noticed in skeletal muscle of residual feed consumption (RFI) excessive animals (RFI-Excessive).
- Conversely, a better abundance of Warmth Shock Protein Beta 1 (P < 0.01) was noticed within the skeletal muscle of RFI-Low cattle. A better mRNA expression of YWHAE, which encodes the 14-3-Three protein epsilon, was additionally noticed within the skeletal muscle of RFI-Excessive animals (P = 0.01).
A decrease mRNA expression of HSPB1, which encodes the Warmth Shock Protein Beta 1, was noticed within the skeletal muscle of RFI-Excessive animals (P = 0.01). The miR-665 was recognized as a possible regulator of the 14-3-Three protein epsilon, and its expression was better in RFI-Low animals (P < .001).
A better expression of miR-34a (P = 0.01) and miR-2899 (P < .001) was noticed within the skeletal muscle of RFI-Excessive animals, as each miRNAs had been recognized as potential regulators of HSPB1 expression.Our outcomes present that Nellore cattle divergently recognized for feed effectivity by RFI current modifications within the abundance of proteins concerned in vitality expenditure in skeletal muscle.
Furthermore, our knowledge level in the direction of that miR-665, miR34a and miR-2899 are doubtless concerned in controlling each 14-3-Three epsilon and HSPB1 proteins recognized as differentially ample within the skeletal muscle of RFI-Excessive and RFI-Low Nellore cattle.
Dnalc4 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K4997502 | ABM | 1.0 ug DNA | EUR 184.8 |
Dnalc4 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K4997503 | ABM | 1.0 ug DNA | EUR 184.8 |
Dnalc4 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K4997504 | ABM | 1.0 ug DNA | EUR 184.8 |
Dnalc4 Protein Vector (Mouse) (pPB-C-His) |
|||
PV172858 | ABM | 500 ng | EUR 723.6 |
Dnalc4 Protein Vector (Mouse) (pPB-N-His) |
|||
PV172859 | ABM | 500 ng | EUR 723.6 |
Dnalc4 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV172860 | ABM | 500 ng | EUR 723.6 |
Dnalc4 Protein Vector (Mouse) (pPM-C-His) |
|||
PV172861 | ABM | 500 ng | EUR 723.6 |
Dnalc4 3'UTR Luciferase Stable Cell Line |
|||
TU105288 | ABM | 1.0 ml | Ask for price |
Dnalc4 3'UTR GFP Stable Cell Line |
|||
TU155288 | ABM | 1.0 ml | Ask for price |
Dnalc4 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K4997505 | ABM | 3 x 1.0 ug | EUR 451.2 |
Dnalc4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K4997506 | ABM | 1.0 ug DNA | EUR 200.4 |
Dnalc4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K4997507 | ABM | 1.0 ug DNA | EUR 200.4 |
Dnalc4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K4997508 | ABM | 1.0 ug DNA | EUR 200.4 |
CD11b Antibody Antibody |
|||
ABD2911 | Lifescience Market | 100 ug | EUR 525.6 |
ASAP1 antibody Antibody |
|||
DF8746 | Affbiotech | 200ul | EUR 420 |
anti- Antibody^Polyclonal antibody control antibody |
|||
LSMab09882 | Lifescience Market | 100 ug | EUR 525.6 |
ARHGDIA Antibody / RHOGDI Antibody |
|||
F54788-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
ARHGDIA Antibody / RHOGDI Antibody |
|||
F54788-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
Antibody |
|||
A1360-500 | Biovision | each | Ask for price |
Anti-Glycolipid Antibody (AGA) Antibody |
|||
20-abx004855 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx008109 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx123734 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx014333 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
abx033330-400ul | Abbexa | 400 ul | EUR 627.6 |
Ly1 Antibody Reactive (LYAR) Antibody |
|||
abx033330-80l | Abbexa | 80 µl | EUR 343.2 |
Anti-Glycolipid Antibody (AGA) Antibody |
|||
abx036399-100ug | Abbexa | 100 ug | EUR 469.2 |
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319900 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319901 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319905 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319913 | Abbexa |
|
|
Anti-Glycolipid Antibody (AGA) Antibody |
|||
abx230204-100ug | Abbexa | 100 ug | EUR 577.2 |
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx324434 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx311665 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
abx234901-100ug | Abbexa | 100 ug | EUR 661.2 |
Anti-Anti-SEPT6 antibody antibody |
|||
STJ11100949 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
Anti-Anti-SEPT9 Antibody antibody |
|||
STJ111369 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ111530 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT4 Antibody antibody |
|||
STJ112276 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
Anti-Anti-MARCH9 Antibody antibody |
|||
STJ112609 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ113941 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ114081 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ114819 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-MARCH8 Antibody antibody |
|||
STJ114828 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ116214 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ117206 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT12 Antibody antibody |
|||
STJ117759 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118549 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118550 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH7 Antibody antibody |
|||
STJ118752 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT3 Antibody antibody |
|||
STJ118990 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ28365 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ28963 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ25475 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ25477 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ25479 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT1 antibody antibody |
|||
STJ119580 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
CLCN5 Antibody / CIC-5 antibody |
|||
RQ6462 | NSJ Bioreagents | 100ug | EUR 419 |
Description: The CLCN5 gene encodes the chloride channel Cl-/H+ exchanger ClC-5. This gene encodes a member of the ClC family of chloride ion channels and ion transporters. The encoded protein is primarily localized to endosomal membranes and may function to facilitate albumin uptake by the renal proximal tubule. Mutations in this gene have been found in Dent disease and renal tubular disorders complicated by nephrolithiasis. Alternatively spliced transcript variants have been found for this gene. |
Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
|||
48169-100ul | SAB | 100ul | EUR 399.6 |
Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
|||
48169-50ul | SAB | 50ul | EUR 286.8 |
Anti CD22 Antibody: CD22 Monoclonal Antibody |
|||
065-A-01mg | Virogen | 0,1 mg | EUR 321 |
Description: anti-CD22 monoclonal antibody |
Anti CD22 Antibody: CD22 Monoclonal Antibody |
|||
065-A-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: anti-CD22 monoclonal antibody |
Antibody Pair to ApoA-V antibody |
|||
10R-1876 | Fitzgerald | 100 ul | EUR 781.2 |
Description: Mouse monoclonal Antibody Pair to ApoA-V antibody |
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|||
20-abx103034 | Abbexa |
|
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|||
20-abx103035 | Abbexa |
|
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|||
20-abx103036 | Abbexa |
|
|
Hepatitis C Virus Antibody (HCV) Antibody |
|||
abx023924-1mg | Abbexa | 1 mg | EUR 1446 |
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319902 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319903 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319904 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319906 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319907 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319908 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319914 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319915 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319916 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319929 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319930 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319931 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (HRP) |
|||
20-abx311666 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (FITC) |
|||
20-abx311667 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (Biotin) |
|||
20-abx311668 | Abbexa |
|
|
Anti-Glycoprotein 210 Antibody (gp210) Antibody |
|||
abx233571-100ug | Abbexa | 100 ug | EUR 577.2 |
Anti Deoxyribonucleic Acid Antibody (DNA) Antibody |
|||
abx411057-50ug | Abbexa | 50 ug | EUR 710.4 |
Monoclonal NGF/proNGF Neutralizing Antibody Antibody |
|||
AMM06679G | Leading Biology | 0.05mg | EUR 633.6 |
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E |
Goat anti- human Antibody^Polyclonal antibody |
|||
LSMab09896 | Lifescience Market | 100 ug | EUR 525.6 |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D | Stressmarq | 0.1mg | EUR 424.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is unconjugated. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A390 | Stressmarq | 0.1mg | EUR 481.2 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 390. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A488 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 488. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A565 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 565. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A594 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 594. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A633 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 633. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A655 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 655. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A680 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 680. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A700 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 700. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-ALP | Stressmarq | 0.1mg | EUR 472.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Alkaline Phosphatase. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-APC | Stressmarq | 0.1mg | EUR 478.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to APC . |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-APCCY7 | Stressmarq | 0.1mg | EUR 565.2 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to APC/Cy7. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-BI | Stressmarq | 0.1mg | EUR 475.2 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Biotin. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-DY350 | Stressmarq | 0.1mg | EUR 496.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 350. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-DY405 | Stressmarq | 0.1mg | EUR 483.6 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 405. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-DY488 | Stressmarq | 0.1mg | EUR 471.6 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 488. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-DY594 | Stressmarq | 0.1mg | EUR 474 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 594. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-DY633 | Stressmarq | 0.1mg | EUR 468 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 633. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-FITC | Stressmarq | 0.1mg | EUR 470.4 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to FITC. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-HRP | Stressmarq | 0.1mg | EUR 465.6 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to HRP. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-P594 | Stressmarq | 0.1mg | EUR 488.4 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to PE/ATTO 594. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-PCP | Stressmarq | 0.1mg | EUR 478.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to PerCP. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-RPE | Stressmarq | 0.1mg | EUR 476.4 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to RPE . |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-STR | Stressmarq | 0.1mg | EUR 477.6 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Streptavidin. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692S | Stressmarq | 0.012mg | EUR 78 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is unconjugated. |
Anti-Noelin Antibody BIOTIN Antibody BIOTIN |
|||
STJ501938 | St John's Laboratory | 100 µg | EUR 703.2 |
Anti-Noelin Antibody FITC Antibody FITC |
|||
STJ501939 | St John's Laboratory | 100 µg | EUR 703.2 |
Anti-Noelin Antibody BIOTIN Antibody BIOTIN |
|||
STJ501940 | St John's Laboratory | 100 µg | EUR 703.2 |
Anti-Noelin Antibody FITC Antibody FITC |
|||
STJ501941 | St John's Laboratory | 100 µg | EUR 703.2 |
Anti-IgG1 Negative Control Antibody antibody |
|||
STJ16100881 | St John's Laboratory | 1 mL | EUR 573.6 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20161-100UG | NSJ Bioreagents | 100ug | EUR 409 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20161BTN-50UG | NSJ Bioreagents | 50ug | EUR 409 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20161SAF-250UG | NSJ Bioreagents | 250ug | EUR 979 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20179-100UG | NSJ Bioreagents | 100ug | EUR 409 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20179BTN-50UG | NSJ Bioreagents | 50ug | EUR 409 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20179SAF-250UG | NSJ Bioreagents | 250ug | EUR 979 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
RQ4975 | NSJ Bioreagents | 100ul | EUR 419 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V9032-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V9032-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V9032IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V9032SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151CF488-100T | NSJ Bioreagents | 100 Tests | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3152-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3152-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3152SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3261-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Antibodies are produced by B lymphocytes, each expressing only one class of light chain. Once set, light chain class remains fixed for the life of the B lymphocyte. In a healthy individual, the total kappa to lambda ratio is roughly 3:1 in serum (measuring intact whole antibodies) or 1:1.5 if measuring free light chains, with a highly divergent ratio indicative of neoplasm. Individual B-cells in lymphoid tissue possess either kappa or lambda light chains, but never both together. Specific rearrangement of lambda light chain of immunoglobulins can lead to loss of some protein coding genes, which does not seem to be functionally relevant (while functionally relevant miR-650 can be overexpressed). Using immunohistochemistry, it is possible to determine the relative abundance of B-cells expressing kappa and lambda light chains. If the lymph node or similar tissue is reactive, or otherwise benign, it should possess a mixture of kappa positive and lambda positive cells. If, however, one type of light chain is significantly more common than the other, the cells are likely all derived from a small clonal population, which may indicate a malignant condition, such as B-cell lymphoma. [Wiki] |